Japan
· Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 365.43 billion. The enterprise value is 371.48 billion.
| Market Cap | 365.43B |
| Enterprise Value | 371.48B |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Organo has 45.97 million shares outstanding. The number of shares has increased by 0.09% in one year.
| Current Share Class | 45.97M |
| Shares Outstanding | 45.97M |
| Shares Change (YoY) | +0.09% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 24.27% |
| Float | 25.48M |
Valuation Ratios
The trailing PE ratio is 15.13 and the forward PE ratio is 14.99.
| PE Ratio | 15.13 |
| Forward PE | 14.99 |
| PS Ratio | 2.24 |
| PB Ratio | 3.02 |
| P/TBV Ratio | 3.05 |
| P/FCF Ratio | 19.40 |
| P/OCF Ratio | 17.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.20, with an EV/FCF ratio of 19.72.
| EV / Earnings | 15.38 |
| EV / Sales | 2.28 |
| EV / EBITDA | 11.20 |
| EV / EBIT | 11.89 |
| EV / FCF | 19.72 |
Financial Position
The company has a current ratio of 2.55, with a Debt / Equity ratio of 0.19.
| Current Ratio | 2.55 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 1.20 |
| Interest Coverage | 126.51 |
Financial Efficiency
Return on equity (ROE) is 21.66% and return on invested capital (ROIC) is 13.78%.
| Return on Equity (ROE) | 21.66% |
| Return on Assets (ROA) | 10.32% |
| Return on Invested Capital (ROIC) | 13.78% |
| Return on Capital Employed (ROCE) | 23.94% |
| Revenue Per Employee | 65.00M |
| Profits Per Employee | 9.61M |
| Employee Count | 2,512 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 4.87 |
Taxes
In the past 12 months, Organo has paid 8.17 billion in taxes.
| Income Tax | 8.17B |
| Effective Tax Rate | 25.25% |
Stock Price Statistics
The stock price has decreased by -2.41% in the last 52 weeks. The beta is 0.83, so Organo's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -2.41% |
| 50-Day Moving Average | 6,968.00 |
| 200-Day Moving Average | 7,421.95 |
| Relative Strength Index (RSI) | 71.57 |
| Average Volume (20 Days) | 180,220 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 163.27 billion and earned 24.15 billion in profits. Earnings per share was 525.36.
| Revenue | 163.27B |
| Gross Profit | 55.18B |
| Operating Income | 31.12B |
| Pretax Income | 32.36B |
| Net Income | 24.15B |
| EBITDA | 33.05B |
| EBIT | 31.12B |
| Earnings Per Share (EPS) | 525.36 |
Balance Sheet
The company has 16.75 billion in cash and 22.56 billion in debt, giving a net cash position of -5.81 billion or -126.31 per share.
| Cash & Cash Equivalents | 16.75B |
| Total Debt | 22.56B |
| Net Cash | -5.81B |
| Net Cash Per Share | -126.31 |
| Equity (Book Value) | 121.19B |
| Book Value Per Share | 2,631.18 |
| Working Capital | 99.97B |
Cash Flow
In the last 12 months, operating cash flow was 21.10 billion and capital expenditures -2.26 billion, giving a free cash flow of 18.84 billion.
| Operating Cash Flow | 21.10B |
| Capital Expenditures | -2.26B |
| Free Cash Flow | 18.84B |
| FCF Per Share | 409.82 |
Margins
Gross margin is 33.80%, with operating and profit margins of 19.06% and 14.79%.
| Gross Margin | 33.80% |
| Operating Margin | 19.06% |
| Pretax Margin | 19.82% |
| Profit Margin | 14.79% |
| EBITDA Margin | 20.24% |
| EBIT Margin | 19.06% |
| FCF Margin | 11.54% |
Dividends & Yields
This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 2.10%.
| Dividend Per Share | 170.00 |
| Dividend Yield | 2.10% |
| Dividend Growth (YoY) | 56.86% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 25.15% |
| Buyback Yield | -0.09% |
| Shareholder Yield | 2.09% |
| Earnings Yield | 6.61% |
| FCF Yield | 5.16% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 5.58 and a Piotroski F-Score of 6.
| Altman Z-Score | 5.58 |
| Piotroski F-Score | 6 |